PDS Biotechnology Corp (PDSB)
3.49
-0.04
(-1.13%)
USD |
NASDAQ |
May 17, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Market Cap: 128.01M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 129.48M |
May 15, 2024 | 128.38M |
May 14, 2024 | 129.66M |
May 13, 2024 | 131.68M |
May 10, 2024 | 128.74M |
May 09, 2024 | 140.48M |
May 08, 2024 | 147.45M |
May 07, 2024 | 138.46M |
May 06, 2024 | 136.81M |
May 03, 2024 | 140.11M |
May 02, 2024 | 136.81M |
May 01, 2024 | 132.41M |
April 30, 2024 | 122.88M |
April 29, 2024 | 124.34M |
April 26, 2024 | 119.94M |
April 25, 2024 | 119.57M |
April 24, 2024 | 119.21M |
April 23, 2024 | 117.37M |
April 22, 2024 | 109.67M |
April 19, 2024 | 97.02M |
April 18, 2024 | 106.37M |
April 17, 2024 | 99.77M |
April 16, 2024 | 102.70M |
April 15, 2024 | 103.44M |
April 12, 2024 | 117.01M |
Date | Value |
---|---|
April 11, 2024 | 123.61M |
April 10, 2024 | 115.54M |
April 09, 2024 | 119.94M |
April 08, 2024 | 121.41M |
April 05, 2024 | 118.47M |
April 04, 2024 | 120.67M |
April 03, 2024 | 134.98M |
April 02, 2024 | 136.45M |
April 01, 2024 | 147.45M |
March 28, 2024 | 145.25M |
March 27, 2024 | 141.22M |
March 26, 2024 | 164.32M |
March 25, 2024 | 173.49M |
March 22, 2024 | 169.46M |
March 21, 2024 | 179.00M |
March 20, 2024 | 159.18M |
March 19, 2024 | 155.21M |
March 18, 2024 | 157.36M |
March 15, 2024 | 162.16M |
March 14, 2024 | 158.36M |
March 13, 2024 | 157.20M |
March 12, 2024 | 153.06M |
March 11, 2024 | 164.15M |
March 08, 2024 | 180.70M |
March 07, 2024 | 192.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.971M
Minimum
Feb 12 2020
485.48M
Maximum
Sep 23 2021
138.59M
Average
132.33M
Median
Aug 22 2022
Market Cap Benchmarks
Syros Pharmaceuticals Inc | 143.78M |
PAVmed Inc | 16.88M |
Altimmune Inc | 567.57M |
Regeneron Pharmaceuticals Inc | 108.27B |
iBio Inc | 6.899M |
Market Cap Related Metrics
Price to Book Value | 4.899 |
Price | 3.49 |
Earnings Yield | -39.83% |